“…Deletion of pepA in A. awamori resulted in an aspergillopepsin A-deficient mutant, with decreased proteolytic activity [125] and able to produce higher levels of bovine chymosin (~430 mg/L), when compared to the control strain (A. awamori strain GC12-∆argB3, ∆pyrG5:~180 mg/L) [128]. A. niger mutants lacking the transcription factor PrtT, which regulates expression of both aspergillopepsin A and B genes (pepA and pepB) [129], showed only 1-2% of the parental strain extracellular protease activity [126] and were used to produce highly stable heterologous cutinase with 1.7-fold increased activity [127]. Stability: Cutinase activity retained at 80% over the entire 14-day incubation period, while the parental lost more than 50% of their initial activities after six days of incubation and retained negligible activity after 14 days -Deletion of dppV and pepA in A. nidulans P. sanguineus laccase activity 500,000 U/mL compared to 40,000 U/mL in the control strain 12.5 [51] Deletion of mnn9 and pepA in A. nidulans P. sanguineus laccase activity 300,000 U/mL compared to 40,000 U/mL in the control strain 7.5 [51] Research on Aspergillus protease repertoire and development of molecular tools for multiple gene targeting allowed the disruption of multiple protease-related genes in a single production host, a successful tactic to further decrease proteolytic degradation and therefore improve protein production titers (Table 10) [51,118,130,131].…”